Related Experiment Video

Updated: Aug 16, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

A review of vaccine research and development: human acute respiratory infections

Marc P Girard1, Thomas Cherian, Yuri Pervikov

  • 1University Paris 7, UFR Biochemistry, 39 rue Seignemartin, FR 69008 Lyon, France. marc.girard36@wanadoo.fr

Vaccine
|September 13, 2005
PubMed

Insights

Acute respiratory infections (ARIs) cause millions of deaths annually, particularly in children. This review examines vaccine research and development (R&D) for ARIs, highlighting needs for broader efficacy and pandemic preparedness.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Acute respiratory infections (ARIs) are a leading cause of mortality worldwide, especially in young children in developing nations.
  • Key pathogens include influenza virus, RSV, PIV-3, Streptococcus pneumoniae, and Haemophilus influenzae.
  • Existing vaccines cover some ARIs (e.g., influenza, Hib, S. pneumoniae), but gaps remain for others like RSV and novel coronaviruses.

Purpose of the Study:

  • To review the current state of vaccine research and development (R&D) for ARIs.
  • To address critical public health questions regarding vaccine efficacy and pandemic preparedness.
  • To identify needs for new vaccines against prevalent and emerging respiratory pathogens.

Main Methods:

  • Literature review of vaccine R&D for ARIs.
  • Analysis of current vaccine availability and efficacy.
  • Discussion of emerging threats and future research directions.

Main Results:

  • Significant mortality burden from ARIs globally, particularly in vulnerable populations.
  • Availability of vaccines for some ARI pathogens, but critical gaps for others like RSV and coronaviruses.
  • Urgent need for broader-spectrum influenza vaccines due to avian influenza outbreaks and pandemic potential.

Conclusions:

  • Vaccine development for ARIs remains a critical public health priority.
  • Further R&D is essential to address existing vaccine gaps and emerging threats.
  • Enhanced vaccine strategies are needed for global health security against respiratory pathogens.

More Related Videos

Influenza A Virus Studies in a Mouse Model of Infection10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.